Arcus Biosciences (RCUS) Other financing activities (2018 - 2026)
Arcus Biosciences (RCUS) posted quarterly Other financing activities of $3.0 million for Q1 2026, down 57.14% quarter-over-quarter from $7.0 million in Q4 2025.
Arcus Biosciences (RCUS) Other financing activities (2018 - 2026) Analysis & Trends
Arcus Biosciences' Other financing activities history runs 9 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $13.0 million (up 62.5% YoY), while the FY2025 annual figure was $10.0 million, up 11.11% from the prior year.
- Other financing activities for Q1 2026 stood at $3.0 million, down from $7.0 million in the prior quarter.
- The five-year high for Other financing activities was $18.0 million in Q4 2022, with the low at -$9.0 million in Q3 2022.
- The 5-year median for Other financing activities is $3.0 million (2023), against an average of $3.5 million.
- Peak annual rise in Other financing activities reached 4190.91% in 2022, while the deepest fall reached 782.85% in 2022.
- Arcus Biosciences' Other financing activities stood at $18.0 million in 2022, then plunged by 83.33% to $3.0 million in 2023, then changed by 0.0% to $3.0 million in 2024, then soared by 133.33% to $7.0 million in 2025, then sank by 57.14% to $3.0 million in 2026.
- Business Quant data shows RCUS's Other financing activities at $3.0 million in Q1 2026, $7.0 million in Q4 2025, and $3.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arcus Biosciences | 3.74 Bn | 3.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.00 Mn |
| Jun 30, 2026 | 16.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |